Nutrition for Precision Health, Powered by the All of Us

NCT05701657 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8000

Last updated 2026-05-01

No results posted yet for this study

Summary

The goal of this Nutrition for Precision Health (NPH) powered by All of Us research study is to develop Artificial Intelligence/Machine Learning (AI/ML) algorithms that predict individual responses to diet patterns using rich multimodal data streams collected across multiple domains (e.g., behavior, social, environmental, clinical and molecular biomarkers). NPH includes a large phenotyping cohort (Module 1, N=8000) and two separate follow-up groups drawn from a subset of Module 1participants. One group (Module 2, N=1200) receives three distinct diets in a 14-day crossover sequence, with at least a 14-day washout period between diets, while living in their own homes. A second group (Module 3, N=150) receives the same three diets under full-time supervision in a residential research setting. We will train and test AI/ML models to predict 0-4 hour postprandial response curves for glucose, insulin, triglycerides, and GLP-1, to the standardized diet-specific meal test (DSMT) collected after each of the three different diets delivered in Module 2. Each diet functions as a controlled stimulus to reveal biological features (such as individual variables, patterns, or clusters of measurements) that best predict a person's response.

The Module 2 DSMT response curves are the primary outcomes (dependent variables) for AI/ML algorithms that predict individual responses to diet patterns.

As a secondary objective, NPH will evaluate the validity and acceptability of technology-based dietary assessment tools. The Automated Self-Administered 24-hour recall (ASA24), Automatic Ingestion Monitor-2 (AIM-2), and the mobile food record (mFR) will be evaluated in Modules 2 and 3, and the ASA24 food record and the image-assisted ASA24 recall will be evaluated only in Module 3. Total energy intake, macronutrient and dietary fiber intake data are the main outcomes for validity testing compared against measures of actual intake. Acceptability will be determined from feedback surveys.

Conditions

  • Nutrition
  • Health
  • Dietary Habits

Interventions

OTHER

Diet A

This diet has high amounts of fruits/vegetables, whole grains, and beans, moderate amounts of dairy, meat/poultry/eggs, nuts/seeds, and olive oil, and very low amounts of sugar sweetened drinks and desserts.

OTHER

Diet B

This diet has high amounts of refined grains, meat/poultry/egg, sugar sweetened drinks, snacks, desserts, and processed foods. It has a moderate amount of dairy and low amounts of fruits/vegetables, whole grains, and fish.

OTHER

Diet C

This diet has moderate-high amounts of vegetables, meat/poultry/egg, nuts/seeds, dairy and fats/oils, low amounts of fruits, and very low amounts of grains and sugars.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH
  • University of North Carolina, Chapel Hill

    collaborator OTHER
  • Northwestern University

    collaborator OTHER
  • Illinois Institute of Technology

    collaborator OTHER
  • University of Chicago

    collaborator OTHER
  • Pennington Biomedical Research Center

    collaborator OTHER
  • Louisiana State University Health Sciences Center in New Orleans

    collaborator OTHER
  • University of California, Davis

    collaborator OTHER
  • University of California, Los Angeles

    collaborator OTHER
  • Cedars-Sinai Medical Center

    collaborator OTHER
  • University of Alabama at Birmingham

    collaborator OTHER
  • Tufts University

    collaborator OTHER
  • Massachusetts General Hospital

    collaborator OTHER
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH
  • National Center for Advancing Translational Sciences (NCATS)

    collaborator NIH
  • National Cancer Institute (NCI)

    collaborator NIH
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH
  • City University of New York, School of Public Health

    collaborator OTHER
  • Mayo Clinic

    collaborator OTHER
  • University of California, San Diego

    collaborator OTHER
  • University of Hawaii

    collaborator OTHER
  • Vanderbilt University Medical Center

    collaborator OTHER
  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH
  • National Institute of Drug Abuse

    collaborator FED
  • Public Health Informatics Computational and Operations Research

    collaborator UNKNOWN
  • University of Southern California

    collaborator OTHER
  • Cornell University

    collaborator OTHER
  • University of Alabama, Tuscaloosa

    collaborator OTHER
  • North Carolina State University

    collaborator OTHER
  • University of North Carolina, Charlotte

    collaborator OTHER
  • Duke University

    collaborator OTHER
  • Stevens Institute of Technology

    collaborator OTHER
  • Purdue University

    collaborator OTHER
  • United States Military Academy West Point

    collaborator FED
  • USDA, Western Human Nutrition Research Center

    collaborator FED
  • North Carolina Central University

    collaborator OTHER
  • Wake Forest University Health Sciences

    collaborator OTHER
  • Boston University

    collaborator OTHER
  • Children's Hospital of Richmond

    collaborator UNKNOWN
  • Virginia Commonwealth University

    collaborator OTHER
  • Verily Life Sciences LLC

    collaborator INDUSTRY
  • Indiana University

    collaborator OTHER
  • Fred Hutchinson Cancer Center

    collaborator OTHER
  • Columbia University

    collaborator OTHER
  • University of Pennsylvania

    collaborator OTHER
  • RTI International

    lead OTHER

Principal Investigators

  • Marie G Gantz, PhD · RTI International

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-14
Primary Completion
2026-12-31
Completion
2027-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05701657 on ClinicalTrials.gov